ResearcherFudan UniversityActive in the last 2 years

Xiaoping Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-3542-4038; OpenAlex author ID A5029850391. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

[Retracted] Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluoroura… Co-author DOI 10.3892/etm.2026.13235 ↗
Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluorouracil and gemc… Co-author DOI 10.3892/etm.2018.7112 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bo Yu · 2 shared papers, 2019–2026 · strength 0.47
- Paper [Retracted] Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and i… DOI 10.3892/etm.2026.13235 ↗
- Paper Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases che… DOI 10.3892/etm.2018.7112 ↗
Qi Zou · 2 shared papers, 2019–2026 · strength 0.47
- Paper [Retracted] Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and i… DOI 10.3892/etm.2026.13235 ↗
- Paper Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases che… DOI 10.3892/etm.2018.7112 ↗
Wei Wang · 1 shared paper, 2019 · strength 0.11
- Paper Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases che… DOI 10.3892/etm.2018.7112 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.